Counsel for Sun Pharmaceutical and Ranbaxy, Devora W. Allon, a partner with Kirkland & Ellis in New York, said that the plaintiffs hired a regulatory expert to say that the Food and Drug Administration moves as fast as it can and that if there had been an earlier target date, the FDA would have met that date.
Leave a Reply